Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404439 · ClinicalTrials.gov registry record · Phase 4
Treatment of Tinnitus With Migraine Medications
A Phase 4 study of Tinnitus and Tinnitus, Subjective, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT04404439 is a Phase 4 study of Tinnitus and Tinnitus, Subjective that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 150 participants, below the 12,613-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04404439, a Phase 4 study of Tinnitus and Tinnitus, Subjective, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It is well-understood that many factors, such as poor education, lower income, or occupational, and recreational activity associated with high noise exposure, influences the prevalence and risk of tinnitus. Although the economic and emotional impact of tinnitus is large, there is currently no FDA-approved medication to treat this condition. However, there are pharmacological options to address the stress, anxiety, and depression that are caused by tinnitus. In this project, we intend to use medications for patients with tinnitus in order to decrease the impact of tinnitus on their daily life and activities.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Nortriptyline + topiramate
- DRUG Verapamil + paroxetine
Study Locations (1)
California
- University of California, Irvine Medical Center ENT Clinic (Pavilion 2) - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2023-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04404439
The ClinicalTrials.gov registry entry for NCT04404439 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,613-participant average among 24 other Tinnitus trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tinnitus appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04404439 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04404439 about?
NCT04404439 is a clinical study titled "Treatment of Tinnitus With Migraine Medications". Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It is well-understood that many factors, such as poor education, lower income, or occupational, and recreational activity a...
What is the current status of trial NCT04404439?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2019-09-26. Estimated completion is 2023-12-30.
What conditions does trial NCT04404439 study?
This clinical trial studies the following conditions: Tinnitus, Tinnitus, Subjective.
What interventions are being tested in trial NCT04404439?
The interventions under investigation include: Placebo (OTHER), Nortriptyline + topiramate (DRUG), Verapamil + paroxetine (DRUG).
Who is sponsoring clinical trial NCT04404439?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404439 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Management of Acute Tinnitus With Migraine Medications
ACTIVE NOT RECRUITING · Phase 4
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
RECRUITING · Early Phase 1
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.